bioRxiv Science⌕ Search

Biology subjects

Papasian, L.

Publications and source records attributed to Papasian, L..

2 recordsLinked to original sources

Deep Learning Identifies BMI-Associated Morphologic Features in Breast Cancer Tissue

Multiple epidemiological studies have established obesity as an adverse factor in breast cancer incidence, progression, and clinical outcomes. However, the biological mechanisms underlying these associations remain incompletely understood. In peritumoral adipose tissue, obesity is associated with chronic inflammation, macrophage recruitment, and broader alterations in the local microenvironment. Whether these obesity-associated changes are accompanied by distinct morphologic features within the tumor and non-adipose stromal compartments remains unclear. In this study, we investigated whether an AI-based pathology foundation model could support the development of machine learning algorithms capable of identifying obesity-associated morphologic patterns in histopathology images, with a particular focus on tumor and stromal regions. In a cohort of 195 patients with breast cancer, machine learning models using vector embeddings from non-adipose stromal regions classified high BMI ([&ge;]30 kg/m2) versus low BMI (<25 kg/m2) with an average AUC of 0.78 (95% CI: 0.73-0.83), consistently outperforming models based on tumor-only or combined tumor-stroma regions. These obesity-associated stromal signatures were observed across subgroups defined by hormone-receptor status and age, indicating that they are not restricted to specific clinical populations. Complementary embedding-based dissimilarity analysis further showed that higher BMI was associated with reduced inter-patient heterogeneity in both tumor and stromal tissues. Overall, these findings suggest that obesity is associated with distinct morphologic alterations in both tumor and non-adipose stromal tissues. Notably, the stromal compartment emerged as a particularly informative indicator of obesity-associated morphology and demonstrated reduced inter-patient heterogeneity among individuals with high BMI.

cancer biology↗

Systematic modeling of phenotypic drug response profiles inpatient-derived organoids

Patient-derived tumor organoids provide a physiologically relevant 3D disease model for preclinical drug discovery, surpassing the limitations of conventional 2D cell lines. To better capture the dynamic nature of organoid drug responses, we developed a new systematic evaluation method called SCOPE (Systematic Classification of Organoids for Phenotypic Evaluation), harnessing phenotypic assessments from multi-timepoint 3D imaging data. By integrating artificial intelligence (AI)-based image analysis of organoid viability with tracking and mathematical modeling of organoid growth over time, we captured temporal-and dose-dependent dynamics of phenotypic changes, culminating in two novel metrics: a combined growth and viability (GV) score as well as a cytostatic-cytotoxic transition range (CCTR) that separates drug effects on organoid growth and viability. Our approach supports classification of specific drug responses into four distinct phenotypic groups: (1) cytotoxic, (2) cytostatic plus cytotoxic, (3) late cytotoxic, and (4) cytostatic. This novel drug evaluation system can identify previously unknown drug effects or new therapeutic use cases for existing drugs, facilitating the design of alternative therapeutic options to overcome efficacy or drug resistance challenges and improving the clinical applicability of organoid-based drug discovery results.

bioengineering↗